April 6, 2017
We're requiring a quantity limit prior authorization for high-risk opioids beginning July 1, 2017, in accordance with the new recommendations from the Centers for Disease Control and Prevention (CDC) for the safe and effective prescribing of opioids. You can read more about Alaska's proposed efforts to better manage opioid abuse.
Medication(s) |
Quantity allowed without review |
Morphine Sulfate ER (Avinza) |
90 capsules of all strengths per 30 days |
Embeda ER |
90 capsules of all strengths per 30 days |
Hydromorphone ER (Exalgo) |
60 tablets of all strengths per 30 days |
Morphine Sulfate ER (Kadian) |
90 capsules of all strengths per 30 days |
Morphine Sulfate ER (MS Contin) |
120 tablets of all strengths per 30 days |
Nucynta (all strengths) |
181 tablets/fill |
Nucynta ER |
60 tablets of all strengths per 30 days |
Oxymorphone ER (Opana ER) |
90 tablets of all strengths per 30 days |
Suboxone film 12/3 mg |
60 films/fill |
Suboxone film 2/0.5 mg, 4/1 mg, 8/2 mg |
90 films/fill |
Buprenorphine-Naloxone tablet 2/0.5 mg, 8/2 mg |
90 tablets/fill |
Zubsolv 1.4/0.36 mg, 5.7/1.4 mg |
90 tablets/fill |
Zubsolv 8.6/2.1 mg |
60 tablets/fill |
What do you need to do?
Review your patient's current dose. If the dose exceeds the new quantity limits, you'll need to submit a prior authorization through electronic prior authorization or fax at 888-260-9836. If you have questions, call Pharmacy Services at 888-261-1756, option 2.